[
[1] Asmar R, Gosse P, Quere S, Achouba A. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood pressure monitoring. 2011 Apr 1;16(2):80-6.10.1097/MBP.0b013e328344c6db21372694
]Search in Google Scholar
[
[2] Dahlöf B. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy. Journal of human hypertension. 2009 Feb;23(2):77.10.1038/jhh.2008.8818685606
]Search in Google Scholar
[
[3] De La Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009 Mar 1;53(3):466-72.10.1161/HYPERTENSIONAHA.108.12400819171788
]Search in Google Scholar
[
[4] Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. American journal of hypertension. 2011 Apr 1;24(4):383-9110.1038/ajh.2010.21720930708
]Search in Google Scholar
[
[5] Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiology international. 2013 Mar 1;30(1-2):280-314.10.3109/07420528.2012.70944823077971
]Search in Google Scholar
[
[6] Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiology international. 2010 Jul 1;27(6):1287-303.10.3109/07420528.2010.48916720653455
]Search in Google Scholar
[
[7] Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. American journal of hypertension. 2008 Aug 1;21(8):948-54.10.1038/ajh.2008.21618600215
]Search in Google Scholar
[
[8] Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K, Tsiachris D, Bilo G, Sideris S, Filis K, Parati G. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. Journal of hypertension. 2015 Feb 1;33(2):393-400.10.1097/HJH.000000000000037125318654
]Search in Google Scholar
[
[9] Langner B, Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. European journal of clinical pharmacology. 1988 Nov 1;33(6):619-24.10.1007/BF005424983366165
]Search in Google Scholar
[
[10] Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacology & therapeutics. 2006 Sep 1;111(3):629-51.10.1016/j.pharmthera.2005.11.00816480770
]Search in Google Scholar
[
[11] Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiology international. 1991 Jan 1;8(6):485-94.10.3109/074205291090591841799930
]Search in Google Scholar
[
[12] Liu X, Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H. Evening-versus morning-dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review. Kidney and Blood Pressure Research. 2014;39(5):427-40.10.1159/00036845625471279
]Search in Google Scholar
[
[13] Liu Y, Ushijima K, Ohmori M, Takada M, Tateishi M, Ando H, Fujimura A. Chronopharmacology of angiotensin II–receptor blockers in stroke-prone spontaneously hypertensive rats. Journal of pharmacological sciences. 2011:1101240507-.10.1254/jphs.10284FP21282930
]Search in Google Scholar
[
[14] Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Journal of hypertension. 2002 Nov 1;20(11):2183-9.10.1097/00004872-200211000-0001712409956
]Search in Google Scholar
[
[15] Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Advanced drug delivery reviews. 2007 Aug 31;59(9-10):952-65.10.1016/j.addr.2006.07.02917675179
]Search in Google Scholar
[
[16] Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep medicine reviews. 2012 Apr 1;16(2):151-66.10.1016/j.smrv.2011.04.00321641838
]Search in Google Scholar
[
[17] Potucek P, Klimas J. Chronotherapy of hypertension with combination treatment. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2013 Dec 2;68(12):921-5.
]Search in Google Scholar
[
[18] Potucek P, Radik M, Doka G, Kralova E, Krenek P, Klimas J. mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats. Clinical and Experimental Hypertension. 2017 Nov 17;39(8):754-63.10.1080/10641963.2017.132448028665713
]Search in Google Scholar
[
[19] Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovascular drugs and therapy. 2003 Jul 1;17(4):335-41.
]Search in Google Scholar
[
[20] Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, de la Sierra A. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016 Apr;67(4):693-700.10.1161/HYPERTENSIONAHA.115.0698126902495
]Search in Google Scholar
[
[21] Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Current pharmaceutical design. 2015 Feb 1;21(6):756-72.10.2174/138161282066614102413001325341857
]Search in Google Scholar
[
[22] Shiga T, Fujimura A, Tateishi T, Ohashi K, Ebihara A. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects. The Journal of Clinical Pharmacology. 1993 Aug;33(8):756-61.10.1002/j.1552-4604.1993.tb05620.x8408738
]Search in Google Scholar
[
[23] Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood pressure monitoring. 2010 Aug 1;15(4):173-80.10.1097/MBP.0b013e32833c730820571367
]Search in Google Scholar
[
[24] Takeda N, Maemura K. Circadian clock and cardiovascular disease. Journal of cardiology. 2011 May 1;57(3):249-56.10.1016/j.jjcc.2011.02.00621441015
]Search in Google Scholar
[
[25] Wu X, Liu Z, Shi G, Xing L, Wang X, Gu X, Qu Z, Dong Z, Xiong J, Gao X, Zhang C. The circadian clock influences heart performance. Journal of biological rhythms. 2011 Oct;26(5):402-11.10.1177/074873041141416821921294
]Search in Google Scholar
[
[26] Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database of Systematic Reviews. 2011(10).10.1002/14651858.CD004184.pub2904037721975743
]Search in Google Scholar
